Sulfamethoxazole prevention study after kidney transplant
Part of Infections, Kidney & urinary clinical trials.
This trial tests how long kidney transplant patients should take a common antibiotic (sulfamethoxazole) to prevent a lung infection called PJP. You may join if you are between 18 and 70 and have had a kidney transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have had a kidney transplant.
- You are willing to take the study medication and follow the schedule.
- You do not have HIV, a sulfa drug allergy, or certain blood conditions.
- You are not pregnant and do not have other organ transplants or active cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different doses of an antibiotic (TMP-SMX) to prevent a serious lung infection called Pneumocystis pneumonia that can occur after kidney transplant. The goal is to find the safest, most effective dose for transplant patients.
This trial tests whether continuing or stopping a specific antibiotic (TMP-SMX) after the first 6 months can prevent urinary tract infections (UTIs) in kidney transplant recipients who are at high risk for them.
This trial tests if giving a specific antibiotic can help prevent bloodstream infections in people who recently had a kidney transplant. It is for patients who have a significant amount of bacteria in their urine within the first month after surgery.
This trial tests whether a faster test for lung infections can help doctors choose the right antibiotics sooner after a lung transplant. It aims to reduce infections and improve recovery.
This trial tests whether a preventive treatment can stop pneumocystis pneumonia (a lung infection) in people with autoimmune inflammatory rheumatic diseases who are taking steroids or other immune-suppressing medicines. It aims to find the safest and most effective way to protect you from this serious infection.
This trial tests whether the antibiotic TMP-SMX is safe and effective for treating a type of pneumonia (PCP) in people who do not have HIV. It aims to find better treatment options for this serious lung infection.
Hear when a new Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.